Search

everythinglearnresearchcommunity

for

Search:↓

New compounds show promise as nonsteroidal treatments for hair loss.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

Geranylgeraniol from nutmeg may effectively treat hair loss, similar to finasteride and better than minoxidil.

DK peptides can reduce hair loss by inhibiting the 5α-reductase enzyme and have antioxidant effects.

Certain herbal compounds might help prevent hair loss in menopausal women by activating Vitamin D receptors.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Some vitamin D analogs can thicken skin and reduce pore size like a common acne treatment, with one analog also affecting skin growth factors.

GLP-1 receptor agonists may cause hair loss, but regrowth is rare.

Eplerenone, a mineralocorticoid receptor antagonist, was found to promote hair growth in human hair follicles.

A new, less toxic and more efficient method to create the anti-baldness compound RU58841 was developed in 2014.

New pyrazole derivatives may help treat hair loss, but more testing is needed.

PM-9 and finasteride effectively inhibit the enzyme that converts testosterone to DHT.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

RU58841 significantly increases hair growth rate and initiates more hair cycles, but doesn't affect hair thickness, suggesting it could be a new treatment for baldness.

Dyclonine can effectively reduce skin issues by inhibiting the TRPV3 channel.

Progesterone initially worsens but later reduces neuropathic pain in mice, through different mechanisms.

Shorter GGN repeats in the androgen receptor gene are linked to androgenetic alopecia.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.

OXTR agonists may promote hair growth and be effective for treating hair loss.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Testosterone affects blood pressure control and inflammation in male rats with endotoxic shock, and blocking certain hormones may help treat it.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

Physcion may help treat hair loss by blocking an enzyme linked to baldness.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.